Adagio Medical Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Adagio Medical Holdings generated cash of -$25,652,000, which is less than the previous year. Cash used in financing activities reached the amount of $21,875,000 last year. Net change in cash is therefore -$4,164,000.
Cash Flow
| 2022 | -485.19K | -500K | 75K |
|---|---|---|---|
| 2023 | -25.65M | -340K | 21.87M |
ADGM Cash Flow Statement (2022 – 2023)
| 2023 | 2022 | |
|---|---|---|
Cash at beginning of period | 5.54M | 501.24K |
Operating activities | ||
Net income | -38.14M | 1.06M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 532K | 495K |
Stock-based compensation expense | 442K | 365K |
| Deferred income tax benefit | 442K | 365K |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | -70K | 33K |
Inventories | -2.97M | 35K |
Accounts payable | 64.63K | -107.18K |
Cash generated by operating activities | -25.65M | -485.19K |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | -333K | -502K |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | -340K | -500K |
Financing activities | ||
Common Stock Issued | 0 | 0 |
Payments for dividends | 0 | 0 |
Repurchases of common stock | -115.07M | 0 |
Repayments of term debt | 21.85M | 120K |
Cash used in financing activities | 21.87M | 75K |
Net Change In Cash | -4.16M | -410.19K |
Cash at end of period | 1.38M | 91.04K |